Atrial natriuretic peptide and oxidative stress

Peptides

Volumn 31, Issue 7, 2010, Pages 1412-1419

  De Vito, Paolo ^a   Incerpi, Sandra ^b   Pedersen, Jens Z ^a   Luly, Paolo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

Author keywords

ANP; Antioxidant; Reactive oxygen species; Superoxide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DIACYLGLYCEROL; FREE RADICAL; PEPTIDE; REACTIVE OXYGEN METABOLITE; RECEPTOR PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

AUTOCRINE EFFECT; CARDIOVASCULAR DISEASE; CELL GROWTH; GROWTH REGULATION; HEART MUSCLE CELL; HEPATOBLASTOMA; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; IMMUNE SYSTEM; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; VASODILATATION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; HUMANS; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 77953124862     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.04.001     Document Type: Review

References (105)

1. Akki A., Zhang M., Murdoch C., Brewer A., and Shah A.M. NADPH oxidase signalling and cardiac myocyte function. J Mol Cell Cardiol 47 (2009) 15-22
2. Anand-Srivastava M.B. Natriuretic peptide receptor-C signalling and regulation. Peptides 26 (2005) 1044-1059
3. Anand-Srivastava M.B., and Trachte G.J. Atrial natriuretic factor receptor and signal transduction. Pharmacol Rev 454 (1993) 455-497
4. Arnold R.S., He J., Remo A., Ritsick D., Yin-Goen Q., Lambeth J.D., et al. Nox1 expression determines cellular reactive oxygen and modulate c-fos-induced growth factor, interleukin-8 and cav-1. Am J Pathol 171 (2007) 2021-2032
5. Babior B.M. NADPH oxidase. Curr Opin Immunol 16 (2004) 42-47
6. Babior B.M. NADPH oxidase: an update. Blood 93 (1999) 1464-1476
7. Baldini P.M., De Vito P., Antenucci D., Vismara D., D'Aquilio F., Luly P., et al. Atrial natriuretic peptide induces cell death in human hepatoblastoma (HepG2) through the involvement of NADPH oxidase. Cell Death Differentiation 11 (2004) 210-212
8. Baldini P.M., De Vito P., D'Aquilio F., Vismara D., Zalfa F., Bagni C., et al. Role of atrial natriuretic peptide in the suppression of lysophosphatidic acid-induced rat aortic smooth muscle (RASM) cell growth. Mol Cell Biochem 272 (2005) 19-28
9. Baldini P.M., De Vito P., Martino A., Fraziano M., Grimaldi C., Luly P., et al. Differential sensitivity of human monocytes and macrophages to ANP: a role of intracellular pH on reactive oxygen species production through the phosholipase involvement. J Leuk Biol 73 (2003) 502-510
10. Baldini P.M., De Vito P., Vismara D., Bagni C., Zalfa F., Minieri M., et al. Atrial natriuretic peptide effects on intracellular pH changes and ROS production in HepG2 cells: role of p38 MAPK and phospholipase D. Cell Physiol Biochem 15 (2005) 77-88
11. Baldini P.M., Incerpi S., Zannetti A., De Vito P., and Luly P. Selective activation by natriuretic factor of phosphatidylcholine-specific phospholipases activities in purified heart muscle plasma membrane. J Mol Cell Cardiol 26 (1994) 1691-1700
12. - mice. J Clin Invest 108 (2001) 1513-1522
13. Berk B.C. Vascular smooth muscle growth: Autocrine growth mechanisms. Physiol Rev 81 (2001) 999-1030
14. Bilzer M., Jaechke H., Vollmar A.M., Paumgartner C., and Gerbes A.L. Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol 276 (1999) 1137-1144
15. Bogdan C. Of microbes, macrophages and nitric oxide. Behring Inst Mitt 99 (1997) 58-72
16. Brenner B., Ballerman B.J., Gunning M.E., and Ziedel M.L. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70 (1990) 665-669
17. Brunner-La Rocca H.P., Kiowski W., Ramsay D., and Sutsch G. Therapeutic benefits of increasing natriuretic peptide levels. Cardiovasc Res 51 (2001) 510-520
18. Byrne J.A., Greve D.J., Bendall J.K., Li J.M., Gove C., Lambeth J.D., et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hyperthrophy. Circ Res 93 2003 (2003) 802-805
19. Cahill P.A., and Hassid A. ANF-C receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity. Am J Physiol 266 (1994) 194-203
20. Carini R., De Cesaris, Splendore R., Domenicotti C., Nitti M.P., Pronzato M.A., et al. Mechanism of hepatocyte protection against hypoxic injury by atrial natriuretic peptide. Hepatology 37 (2003) 277-285
21. Cathcart M.K. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages. Contribution to atherosclerosis. Arteroscler Thromb Vasc Biol 24 (2004) 23-28
22. Chan E.C., Jiang F., Peshavariya H.M., and Dusting G.J. Regulation of cell proliferation by NADPH oxidase-mediated signaling:potential roles in tissue repair, regenerative medicine and tissue engineering. Phamacol Therapeutics 122 (2009) 97-108
23. Chang T., and Wu L. Methylglyoxal, oxidative stress and hypertension. Can J Physiol Pharmacol 84 (2006) 1229-1238
24. Choi H., Leto T.L., Hunyady L., Catt K.J., Bae Y.S., and Rhee S.G. Mechanism of angiotensin II-induced superoxide production in cell reconstituted with angiotensin type 1receptor and the component of NADPH oxidase. J Biol Chem 283 (2008) 255-267
25. Date M.O., Morita T., Yamashita N., Nishida K., Yamaguchi O., Higuchi Y., et al. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in vivo murine pressure-overload model. J Am Coll Cardiol 39 (2002) 907-912
26. de Bold A.J., Borestein H.B., Veress A., and Sonnerberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rat. Life Sci 8 (1981) 89-94
27. 2+ changes in rat aortic smooth muscle cells. The role of atrial natriuretic peptide. Mol Cell Biochem 252 (2003) 353-362
28. Dourron H.M., Jacobson G.M., Park J.L., Reddy D.J., Scheel M.L., and Pagano P.J. Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of carotid artery. Am J Physiol 288 (2005) H946-H953
29. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
30. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 15 (2003) 247-254
31. Furst R., Brueckl C., Kuebler W.M., Zahler S., Krotz F., Gorlach A., et al. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac-1 and NAD(P)H oxidase/Nox2-activation. Circ Res 96 (2005) 43-53
32. Garbers D.L. Guanylate cyclase, a cell surface receptor. J Biol Chem 264 (1989) 9103-9106
33. Garg R., and Pandey K.N. Regulation of guanylyl cyclase/natriuretic peptide receptor-A gene expression. Peptides 26 (2005) 1009-1023
34. Gavazzi G., Banfi B., Deffert C., Fiette L., Schappi M., Herrmann F., et al. Decreased blood pressure in NOX1-deficient mice. FEBS Lett 580 (2006) 497-504
35. 2+ selectively suppresses IL-1-induced NO production by reducing iNOS mRNA stability. J Cell Biol 129 (1995) 1651-1657
36. Gerwitz T., Meissner H., Bilzer M., Kiemer A.K., Arnholdt H., Vollmar A.M., et al. Atrial natriuretic peptide preconditioning protects against hepatic preservation injury by attenuating necrotic and apoptotic cell death. J Hepatol 39 (2003) 428-430
37. Giannello P., Carlier M., Jamart J., Hulhoven R., Bernheim J., Bernard A., et al. Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation. Clin Transplant 9 (1995) 481-489
38. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115 (2005) 500-508
39. 2+ efflux. J Biol Chem 47 (2007) 34542-34554
40. 2+ fluxes in rat hepatocytes. Gastroenterol 123 (2002) 1291-1303
41. Hancock J.T., Desikan R., and Neill S.J. Role of reactive oxygen species in cell signaling pathways. Biochem Soc Trans 29 (2001) 345-350
42. Huwiler A., Kolter T., Pfelshifter J., and Sandhoff K. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 1485 (2000) 63-99
43. Ide T., Tsutsui H., Kinugawa S., Suematsu N., Hayashidani S., Ichikawa K., et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 86 (2000) 152-157
44. Inoue C.N., Ko Y.H., Guggino W.B., Forster H.G., and Epstein M. Lysophosphatidic acid and platelet-derived growth synergistically stimulate growth of cultured rat mesangial cells. Proc Soc Exp Biol Med 216 (1997) 370-379
45. Ishigaki N., Yamamoto N., Jin H., Uchida K., Terai S., and Sakaida J. Continuous intravenous infusion of atrial natriuretic peptide (ANP) prevented liver fibrosis in rat. Biochem Biophys Res Commun 378 (2009) 354-359
46. Iwamoto I., Kimura A., Ochiaik, Tomioka H., and Yoshida J. Distribution of neuronal endopeptidase activity in human blood leukocytes. J Leuk Biol 49 (1991) 116-125
47. Jalink K., Hordijk P.L., and Moolenar W.H. Growth factor-like effects of phosphatidic acid, a novel lipid mediator. Biochim Biophys Acta 1198 (1994) 185-196
48. Kangawa K., and Matsuo H. Purification and complete amino acid sequence of α human atrial natriuretic polypeptide (α-h ANP). Biochem Biophys Res Commun 118 (1984) 131-139
49. Kiemer A.K., and Vollmar A.M. Autocrine regulation of inducible nitric oxide synthase in macrophages by atrial natriuretic peptide. J Biol Chem 273 (1998) 13444-13451
50. Kiemer A.K., and Vollmar A.M. Induction of L-arginine transport is inhibited by ANP: a peptide hormone as a novel regulator of iNOS substrate availability. Mol Pharmacol 60 (2001) 421-426
51. Kiemer A.K., Hartung T., and Vollmar A.M. cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J Immunol 165 (2000) 175-181
52. Kiemer A.K., Gerbes A.L., Bilzer M., and Vollmar A.M. Atrial natriuretic peptide and cGMP: novel activators of the heat shock protein in rat livers. Hepatology 35 (2002) 88-94
53. Kiemer A.K., Gerwig T., Gerbes A.L., Meissener H., Bilzer M., and Vollmar A.M. Kupffer-cell specific induction of heme oxygenase 1 (hsp32) by the atrial natriuretic peptide-role of cGMP. J Hepatol 38 (2003) 490-498
54. Kiemer A.K., Kulhnek-Heinze S., Gerwiq T., Gerbes A.L., and Vollmar A.M. Stimulation of p38 MAPK by hormonal preconditioning with atrial natriuretic peptide. World J Gastroenterol 8 (2002) 707-711
55. Kiemer A.K., Lehner M.D., Hartung T., and Vollmar A.M. Inhibition of cyclooxygenase-2 by natriuretic peptides. Endocrinology 143 (2002) 846-852
56. Kiemer A.K., and Vollmar A.M. Elevation of intracellular calcium levels contributes to the inhibition of inducible nitric oxide synthase by atrial natriuretic peptide. Immunol Cell Biol 79 (2001) 11-17
57. Kinugawa S., Tsutsui H., Hayashidani S., Ide T., Suematsu N., Satoh S., et al. Treatment with dimethylthiourea prevents left ventricular remodelling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res 87 (2000) 392-398
58. Kirsch B. Electron microscopy of the atrium of the heart. Exp Med Surg 14 (1956) 99-111
59. Koller K.J., and Goeddel D.V. Molecular biology of natriuretic peptides and their receptors. Circulation 86 (1992) 1081-1088
60. Lappas G., Daou G.B., and Anand-Srivastava M.B. Oxidative stress contributes to the enhanced expression of Giα proteins and adenylyl cyclase signaling in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 23 (2005) 2251-2261
61. Laskowski A., Woodman O.L., Cao A.H., Drummond G.R., Marshall T., Kaye D.M., et al. Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 72 (2006) 112-123
62. Li J.M., Gall N.P., Grieve D.J., Chen M., and Shah A.M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40 (2002) 477-484
63. Li M., and Fukagawa N.K. Age-related changes in redox signalling and VSMC function. Antiox Redox Signal 1 (2010) 641-655
64. Lima J.J., Mohapetra S., Feng H., Lockey R., Jena P.K., Castro M., et al. A polymorphism in the NPRA gene associates with asthma. Clin Exp Allergy 38 (2008) 1117-1123
65. Luft F.C., Lang R.E., Aranoff G.R., Ruskoaho H., Toth M., Ganten D., et al. Atriopeptin III kinetics and pharmacodynamics in normal and anephric rat. J Pharmacol Exp Ther 236 (1986) 416-418
66. Mc Grath M.F., and de Bold A.J. Determinants of natriuretic peptide gene expression. Peptides 26 (2005) 933-943
67. Mc Murray J., Chopra M., Abdullah I., Smith W.E., and Dargie H.J. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 14 (1993) 1493-1498
68. Nakano Y., Longo-Guess C.M., Bergstrom D.E., Nauseef W.M., Jones S.M., and Banfi B. Mutation of the Cyba gene encoding p22phox causes vestibular and immune defects in mice. J Clin Invest 118 (2008) 1176-1185
69. Nigwekar S.U., Navaneethan S.D., Parich C.R., and Hix J.K. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 4 (2009) 261-272
70. Okawa H., Horimoto H., Mieno S., Nomura Y., Nakahara K., Yoshida M., et al. Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotection through a nitric oxide-dependent mechanism. J Cardiol 39 (2002) 299-304
71. Omland T., and Hagve T.A. Atrial natriuretic peptide: physiologic and analytic consideration. Heart Fail Clin 5 (2009) 471-487
72. Pandey K.N. Internalization and trafficking of guanylyl cyclase/natriuretic peptide receptor-A. Peptides 26 (2005) 985-1000
73. Pechanova O., and Simko F. Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind. J Hypertens 27 (2009) 32-36
74. Penna C., Mancardi D., Rastaldo R., and Pagliaro P. Cardioprotection: a radical view. Free radicals in pre and postconditioning. Biochim Biophys Acta 87 (2009) 781-793
75. Potter L.R., Yoder A.R., Flora D.R., Antos L.K., and Dickey M.D. Natriuretic peptides: Structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 191 (2009) 341-366
76. Powers S.K., and Jackson M.J. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 88 (2008) 1243-1276
77. Rashed H.M., Sun H., and Patel T.B. Atrial natriuretic peptide inhibits growth of hepatoblastoma HEPG2 cells by means of activation of clearance receptors. Hepatology 17 (1993) 677-684
78. Ricci R., Baldini P., Bogetto L., De Vito P., Luly P., Zannetti A., et al. Dual modulation of Na/H antiport by atrial natriuretic factor in rat aortic smooth muscle cells. Am J Physiol 273 (1997) C643-C652
79. Rivad A., and Andres V. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol Histopathol 15 (2000) 557-571
80. Rojkind M., Dominguez-Rosales J.A., Nieto N., and Greenwel P. Role of hydrogen peroxide and oxidative stress in healing responses. Cell Mol Life Sci 59 (2002) 1872-1891
81. Rubattu S., and Volpe M. The atrial natriuretic peptide: a changing view. J Hypertens 19 (2001) 1923-1931
82. Ruskoaho H. Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol Rev 574 (1992) 481-516
83. Sabbatini M.E. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system. Regul Pept 154 (2009) 5-15
84. Saha S., Li Y., Lappas G., and Anand-Srivastava M.B. Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Giα protein. J Mol Cell Card 44 (2008) 336-344
85. Schultz E., and Munzel T. Nox5, a new "radical" player in human atherosclerosis. J Am Cell Cardiol 52 (2008) 1810-1812
86. Sedeek M., Hebert R.L., Kennedy C.R., Burns K.D., and Touyz R.M. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr Opin Nephrol Hypertens 18 (2009) 122-127
87. Shono M., Yoshimura M., Nakayama M., Yamamuro M., Abe K., Suzuki S., et al. Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during treatment of patients with heart failure. Circ J 71 (2007) 1040-1046
88. Sia Y.T., Lapointe N., Parker T.G., Tsoporis J.N., Deschepper C.F., Calderone A., et al. Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat. Circulation 105 (2002) 2549-2555
89. Silberbach M., and Roberts C.T. Natriuretic peptide signalling. Molecular and cellular pathways to growth regulation. Cell Signal 13 (2001) 221-231
90. Siwik D.A., Tzortzis J.D., Pimental D.R., Chang D.L., Pagano P.J., Singh K., et al. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 85 (1999) 147-153
91. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., et al. Cell transformation by the superoxide-generating oxidase Nox1. Nature 401 (1999) 79-82
92. Tauber A.I., Borregaard N., Simons E., and Wright J. Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies. Medicine 62 (1983) 286-389
93. Tigyi G., Dyer D.L., and Miledi R. Lysophosphatidic acid possesses dual action in cell proliferation. Proc Natl Acad Sci USA 91 (1994) 1908-1912
94. Tsujimoto I., Hikoso S., Yamaguchi O., Kashiwase K., Nakai A., Takeda T., et al. The antioxidant edaravone attenuates pressure overload-induced left ventricular hyperthrophy. Hypertension 45 (2005) 921-926
95. Vaquero E.C., Edderkaoui M., Pandol S., Gukovsky I., and Gukovskaya A.S. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 279 (2004) 34643-34654
96. Vaughan-Jones R.D., and Swietach P. Pushing and pulling the cardiac sodium/hydrogen exchanger. Circ Res 103 (2008) 773-775
97. Vignais P.V. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59 (2002) 1428-1459
98. Vollmar A.M., and Kiemer A.K. Immunomodulatory and cytoprotective function of atrial natriuretic peptide. Crit Rev Immunol 6 (2001) 473-489
99. Vollmar A.M. The role of atrial natriuretic peptide in the immune system. Peptides 26 (2005) 1086-1094
100. Vollmar A.M., Paumgartner G., and Gerbes A.L. Differential gene expression of natriuretic peptide and natriuretic peptide receptors subtype in human liver. Gut 40 (1997) 145-150
101. Weigert A., and Brune B. Nitric oxide, apoptosis and macrophage polarization during tumor progression. Nitric Oxide 19 (2008) 95-102
102. Wolin M.S. Reactive oxygen species and the control of vascular function. Am. J. Physiol. 296 (2009) H539-H549
103. Woodard G.E., and Rosado J.A. Natriuretic peptides in vascular physiology and pathology. Int Rev Cell Mol Biol 268 (2008) 59-93
104. Yamaji M., Tsutamoto T., Tanaka T., Kawahara C., Nishigawa K., Yamamoto T., et al. Effect of carperitide on plasma adiponectin in acute decompensated heart failure patients with diabetes mellitus. Circ J 73 (2009) 2264-2269
105. Zamproni I., Grasberger H., Cortinov F., Vignone M.C., Chiumello G., Mora S., et al. Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypertyroidism. J Clin Endocrinol Metab 93 (2008) 605-610